Effects of Raloxifene, One of the Selective Estrogen Receptor Modulators, on Pituitary–Ovary Axis and Prolactin in Postmenopausal Women

References

Page 1

	Year	Citations
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial JAMA	2002	15.7K
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE> Bruce Ettinger JAMA	1999	3.4K
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer The Lancet	1997	2.5K
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women Valery T. Miller JAMA Hormonal ContraceptiveHeart FailureGynecologyMenopausal Hormone TherapyPharmacotherapy	1995	2.3K
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women Sally A. Shumaker, Claudine Legault, Stephen R. Rapp, JAMA	2003	2.2K
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women Steven R. Cummings, Stephen Eckert, K A Krueger, JAMA	1999	1.9K
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites Kolja Paech, Paul Webb, George G. J. M. Kuiper, Science	1997	1.9K
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women Pierre D. Delmas, Nina H. Bjarnason, Bruce Mitlak, New England Journal of Medicine	1997	1.6K
Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333 Dr Ailsa Gebbie Journal of Family Planning and Reproductive Health Care	2002	1.2K
The effect of raloxifene on risk of breast cancer in postmenopausal women : results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation Steven R. Cummings Medical Entomology and Zoology Breast OncologyOncologyCancer EpidemiologyMore Randomized TrialCancer Risk	1999	796

Page 1